TT-232| ChemScene

TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. TT-232 inhibits cancer cell proliferation and induces apoptosis. TT-232 is also a broad-spectrum anti-inflammatory and analgesic agent[2].In Vitro:TT-232 (10 μg/mL, 48 h) induces apoptosis in human colon (HT-29 and SW620), pancreatic (818), leukemia (K-562), melanoma (WM 938/B, M-1 and EP) and lymphoma (HT-58) tumor cell lines.
TT-232 (20-30 μg/mL, 24 h) shows antiproliferative effect on various human tumor cell lines[2].
In Vivo:TT-232 (15-750 μg/kg/day, twice a day) inhibits tumor growth in mice transplanted with Colon 26 cell[2].
TT-232 (0.6 or 15 μg/kg s.c or i.p.) shows antitumor effect on P-388 rodent lymphocytic leukemia tumor mice.
TT-232 (7.5-20 μg/kg, i.v.) inhibits Carrageenin-induced paw oedema in rats.

Price Not Available 1mg TT-232| ChemScene Supplier Page
Trivial name TT-232
Catalog Number CS-0025194
Alternative Name(s) CAP-232; TLN-232
Molecular Formula 947.13
CAS# 147159-51-1
Purity >98%
Condensed Formula C45H58N10O9S2
Size 1mg
Supplier Page www.chemscene.com/147159-51-1.html